NZ

Novozymes A/SCSE Novozymes Stock Report

Last reporting period 31 Dec, 2023

Updated —

Last price

Market cap $B

10.852

Large

Exchange

XCSE - Nasdaq Copenhagen A/S

View Section: Financials

Novozymes Statements

NZ

Novozymes Income Statement

B

M

DKK (except Earnings per share)

Financial

Revenue

Cost of sales

Gross profit

Research and development

Selling, general and administrative

Total operating expenses

Operating income

Interest expense

Other income

Income before tax

Provision for income taxes

Net income

Diluted earnings per share

Shares outstanding after dilution

2023-12-31
%

4 603

100

2 118

46

2 485

54

524

11.4

842

18.3

1 328

28.9

1 157

25.1

-1

-0.02

-31

-0.7

923

20.1

228

5

698

15.2

2.507

278.4

2023-09-30
%

4 456

100

2 058

46.2

2 398

53.8

461

10.3

767

17.2

1 214

27.2

1 184

26.6

5

0.1

121

2.7

1 148

25.8

219

4.9

936

21

3.371

277.7

2023-06-30
%

4 217

100

1 881

44.6

2 336

55.4

515

12.2

825

19.6

1 325

31.4

1 011

24

-54

-1.3

-13

-0.3

798

18.9

184

4.4

606

14.4

2.181

277.9

2023-03-31
%

4 623

100

2 120

45.9

2 503

54.1

517

11.2

890

19.3

1 303

28.2

1 200

26

-67

-1.4

-27

-0.6

1 040

22.5

239

5.2

784

17

2.822

277.8

2022-12-31
%

4 529

100

2 106

46.5

2 423

53.5

535

11.8

803

17.7

1 333

29.4

1 090

24.1

70

1.5

-47

-1.04

1 045

23.1

168

3.7

883

19.5

3.177

277.94

2022-09-30
%

4 367

100

2 019

46.2

2 348

53.8

475

10.9

826

18.9

1 061

24.3

1 287

29.5

-104

-2.4

205

4.7

1 388

31.8

235

5.4

1 152

26.4

4.138

278.4

2022-06-30
%

4 286

100

1 907

44.5

2 379

55.5

498

11.6

790

18.4

1 269

29.6

1 110

25.9

-95

-2.2

32

0.7

1 047

24.4

230

5.4

809

18.9

2.895

279.4

2022-03-31
%

4 371

100

1 944

44.5

2 427

55.5

493

11.3

804

18.4

1 285

29.4

1 142

26.1

-57

-1.3

-9

-0.2

1 076

24.6

237

5.4

832

19

2.977

279.5

2021-12-31
%

3 834

100

1 685

43.9

2 149

56.1

512

13.4

870

22.7

1 344

35.1

805

21

-153

-4

119

3.1

771

20.1

148

3.9

625

16.3

2.234

279.71

2021-09-30
%

3 761

100

1 584

42.1

2 177

57.9

435

11.6

657

17.5

1 082

28.8

1 095

29.1

-20

-0.5

-21

-0.6

1 054

28

211

5.6

842

22.4

3.009

279.8

2021-06-30
%

3 580

100

1 479

41.3

2 101

58.7

499

13.9

631

17.6

1 111

31

990

27.7

21

0.6

-18

-0.5

993

27.7

199

5.6

794

22.2

2.829

280.7

2021-03-31
%

3 776

100

1 580

41.8

2 196

58.2

563

14.9

637

16.9

1 079

28.6

1 117

29.6

16

0.4

-27

-0.7

1 106

29.3

221

5.9

885

23.4

3.151

280.9

2020-12-31
%

3 446

100

1 535

44.5

1 911

55.5

530

15.4

588

17.1

1 115

32.4

796

23.1

27

0.8

-17

-0.5

806

23.4

152

4.4

654

19

2.328

280.89

2020-09-30
%

3 431

100

1 506

43.9

1 925

56.1

477

13.9

562

16.4

1 031

30

894

26.1

4

0.1

-10

-0.3

888

25.9

177

5.2

711

20.7

2.527

281.4

2020-06-30
%

3 349

100

1 492

44.6

1 857

55.4

470

14

542

16.2

990

29.6

867

25.9

-43

-1.3

-16

-0.5

808

24.1

162

4.8

645

19.3

2.284

282.4

2020-03-31
%

3 786

100

1 626

42.9

2 160

57.1

460

12.2

628

16.6

1 065

28.1

1 095

28.9

-72

-1.9

-4

-0.1

1 019

26.9

204

5.4

815

21.5

2.876

283.4

2019-12-31
%

3 731

100

1 654

44.3

2 077

55.7

443

11.9

581

15.6

974

26.1

1 103

29.6

114

3.1

-158

-4.2

1 059

28.4

137

3.7

922

24.7

3.253

283.41

2019-09-30
%

3 704

100

1 647

44.5

2 057

55.5

520

14

690

18.6

1 205

32.5

852

23

-79

-2.1

-2

-0.05

771

20.8

133

3.6

638

17.2

2.233

285.7

2019-06-30
%

3 458

100

1 571

45.4

1 887

54.6

545

15.8

608

17.6

698

20.2

1 189

34.4

-74

-2.1

-6

-0.2

1 109

32.1

211

6.1

898

26

3.117

288.1

2019-03-31
%

3 481

100

1 548

44.5

1 933

55.5

458

13.2

590

16.9

1 038

29.8

895

25.7

-25

-0.7

-10

-0.3

860

24.7

163

4.7

696

20

2.41

288.8

View Section: Balance Sheet